Latest News of VXRT
While institutions invested in Vaxart, Inc. (NASDAQ:VXRT) benefited from last week's 23% gain, retail investors stood to gain the most
By Yahoo! Finance |
5 months ago
Retail investors have significant control over Vaxart, giving them influence on management decisions. Institutions own 11%, while hedge funds have no substantial investment. The general public holds 5...
Vaxart, Inc. (VXRT) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance |
5 months ago
Vaxart, Inc. is a biotech company focusing on oral recombinant protein vaccines. They are developing vaccines for norovirus, coronavirus, seasonal influenza, and HPV, with products in various stages o...